Delivery Order SPE2DB22D3016-SPE2DB24FBFG5
- Not listed
- This federal contract award, valued at $19,828.20, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of Dupixent 300 mg/2 ml pens, a pharmaceutical product used for medical purposes. This is a delivery order contract with a firm fixed price pricing type. The period of performance extends through August 9, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,225.80 firm-fixed-price delivery order is for the supply of Dupixent 200 mg/1.14 ml pens, a specialty medication used to treat various medical conditions. The contract has an ultimate completion date of October 25, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,556.72 firm-fixed-price delivery order is for the supply of Dupixent 300 mg/2 ml pens, with a completion date of November 15, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, was issued by the Defense Logistics Agency (DLA) for the delivery of Dupixent 300 mg/2 ml pen (2 ml). The award, valued at $8,474.19, is a firm-fixed-price delivery order with a completion date of July 12, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is a delivery order worth $19,560.64 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of Dupixent 300 mg/2 ml pens, a prescription medication. The contract has a period of performance through June 12, 2024 and is a firm fixed-price arrangement. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Dupixent 200 mg/1.14 ml pens. The $17,557.70 Firm Fixed Price contract was awarded on December 19, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, with a final completion date of December 20, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $15,701.69 for the supply of Dupixent 300 mg/2 ml pens. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of November 19, 2024. The contract is a Firm Fixed Price arrangement with no set-aside designation. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, provides for the delivery of Dupixent 200 mg/1.14 ml pens for the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $18,468.00, has a completion date of September 16, 2024. It is a delivery order under an Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at up to $999,999,999 through December 2025, for supplying a comprehensive range of medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,570.57 firm fixed price delivery order is for the supply of Dupixent 200 mg/1.14 ml pens, a specialty medication used to treat certain medical conditions. The contract has an ultimate completion date of October 22, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The contract is for the supply of Dupixent 300 mg/2 ml pens, a specialty pharmaceutical product, to support federal healthcare programs. The award has a ceiling value of $7,061.31 and a completion date of August 8, 2024. The contract is a firm-fixed-price arrangement with no set-aside...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB24FBFG5Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of Dupixent 200 mg/1.14 ml pens. The contract is a Delivery Order with a Firm Fixed Price type, valued at $14,400.20, and has an ultimate completion date of August 28, 2024. The award is not associated with a set-aside program. As a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, Amerisourcebergen leverages its extensive supply chain network to provide a wide range of essential medical commodities to support various government agencies and healthcare programs. The company holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation, valued at up to $999,999,999 and $750,000 respectively, for delivering a comprehensive range of medical supplies and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.4k | 8/27/24 |